483
Morton Grove Pharmaceuticals, Inc.Morton Grove Pharmaceuticals, Inc. – FDA 483
Record Details
Morton Grove Pharmaceuticals received a Form 483 detailing significant deficiencies across its quality control unit, laboratory operations, and manufacturing processes. The inspection revealed issues including data integrity concerns, inadequate investigations into discrepancies, and failures in equipment maintenance and environmental controls. These findings indicate a lack of adherence to cGMP requirements, potentially impacting the quality and purity of distributed drug products.
- Product type
- drugs
View Company Profile
ID · 0fbea83f-1f82-4087-a896-461d44ec0c82
Other documents for Morton Grove Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.